Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02208687
Other study ID # 2014/077
Secondary ID
Status Completed
Phase N/A
First received August 4, 2014
Last updated November 6, 2017
Start date August 2014
Est. completion date May 2017

Study information

Verified date April 2016
Source Radboud University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Fatigue is present in at least 60% of the patients with a muscle disease and can be the most disabling symptom. In combination with other impairments, this often results in low levels of physical activity and decreased social participation, leading to large societal costs. Energetic is a self-management group program aimed at improving participation and physical endurance in these patients. Our hypothesis is that Energetic results in improved participation and improved physical endurance, less experienced fatigue and better quality of life compared to usual care, without increasing health care costs.


Recruitment information / eligibility

Status Completed
Enrollment 53
Est. completion date May 2017
Est. primary completion date November 2016
Accepts healthy volunteers No
Gender All
Age group 18 Years to 85 Years
Eligibility Inclusion Criteria:

- formal diagnosis of muscular disease, either FascioScapuloHumeral Dystrophy (FSHD), Inclusion Body Myositis (IBM), Mitochondrial Myopathy (MM) or any other;

- being severely fatigued

- being cardiopulmonary stable and capable of aerobic training (as determined using a submaximal cycling exercise test with ECG (electrocardiography) and advice from a consultant cardiologist and pulmonologist);

- being motivated, committed to the program, and 'ready to change' which is discussed with the patient during the screening by a rehabilitation physician and an occupational therapist; to this end, motivational interviewing will be used (including a advantages/disadvantages matrix; a visual analogue scale (VAS) to rate the importance of participation in de program; and a VAS to rate the confidence a patient has that participation in the program is feasible)

- being able to formulate at least 3 individual participation goals during the interview with the occupational therapist.

Exclusion Criteria:

- active depression or other psychiatric disorder as indicated by a consultant psychologist or by the medical history,

- pregnancy,

- severe co-morbid condition,

- having participated in the Energetic program before

- a travel distance perceived as too burdensome

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Energetic
Physiotherapy and occupational therapy aimed at reconditioning and social participation.
Other:
Control group
Usual care

Locations

Country Name City State
Netherlands Radboudumc Nijmegen Gelderland

Sponsors (4)

Lead Sponsor Collaborator
Radboud University Center of expertise Sneller herstel, Revalidatiefonds Nederland, ZonMw: The Netherlands Organisation for Health Research and Development

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary Canadian Occupational Performance Measure (COPM) Perceived activity performance. Three months will be the primary analysis. Effects at follow up will be measured at 6 and 12 months (see secondary outcome measures) (patient) 3 months
Secondary Canadian Occupational Performance Measure (COPM-satisfaction) Perceived satisfaction with performance (patient) 3 months
Secondary Canadian Occupational Performance Measure (COPM-satisfaction) Perceived satisfaction with performance (patient) 6 months
Secondary Canadian Occupational Performance Measure (COPM-satisfaction) Perceived satisfaction with performance (patient) 15 months
Secondary Canadian Occupational Performance Measure (COPM-performance) Perceived performance in activities. Is primary outcome measure at 3 months, but data of 6 and 15 months follow up wil be used in a secondary analysis. (patient) 6 months
Secondary Canadian Occupational Performance Measure (COPM-performance) Perceived performance in activities. Is primary outcome measure at 3 months, but data of 6 and 15 months follow up wil be used in a secondary analysis. (patient) 15 months
Secondary Activity Card Sort (ACS) Participation measure:% retained activities.(patient) 3 months
Secondary Activity Card Sort (ACS) Participation measure:% retained activities.(patient) 6 months
Secondary Activity Card Sort (ACS) Participation measure:% retained activities.(patient) 15 months
Secondary Six Minutes Walking Test (6MWT) physical endurance, sub-max test. (patient) 3 months
Secondary Six Minutes Walking Test (6MWT) physical endurance, sub-max test. (patient) 6 months
Secondary Six Minutes Walking Test (6MWT) physical endurance, sub-max test. (patient) 15 months
Secondary Health care cost Evaluation health care cost (patient) 3 months
Secondary Health care cost Evaluation health care cost (patient) 6 months
Secondary Health care cost Evaluation health care cost (patient) 15 months
Secondary Checklist Individual Strength subscale fatigue (CIS-fatigue) Impact of fatigue (patient) 3 months
Secondary Checklist Individual Strength subscale fatigue (CIS-fatigue) Impact of fatigue (patient) 6 months
Secondary Checklist Individual Strength subscale fatigue (CIS-fatigue) Impact of fatigue (patient) 15 months
Secondary Health-related Quality of Life: Short Form 36 (SF-36) Quality of life, used for evaluation of cost effectiveness (patient) 3 months
Secondary Health-related Quality of Life: Short Form 36 (SF-36) Quality of life, used for evaluation of cost effectiveness (patient) 6 months
Secondary Health-related Quality of Life: Short Form 36 (SF-36) Quality of life, used for evaluation of cost effectiveness (patient) 15 months
Secondary General Self-Efficacy Scale Evaluation of the perceived self-efficacy (patient) 3 months
Secondary General Self-Efficacy Scale Evaluation of the perceived self-efficacy (patient) 6 months
Secondary General Self-Efficacy Scale Evaluation of the perceived self-efficacy (patient) 15 months
Secondary Hospital Anxiety and Depression Scale (HADS) Anxiety and depression (patient) 3 months
Secondary Hospital Anxiety and Depression Scale (HADS) Anxiety and depression (patient) 6 months
Secondary Hospital Anxiety and Depression Scale (HADS) Anxiety and depression (patient) 15 months
Secondary Zarit Burden Inventory (ZBI) Perceived caregiver burden (caregiver) 3 months
Secondary Zarit Burden Inventory (ZBI) Perceived caregiver burden (caregiver) 6 months
Secondary Zarit Burden Inventory (ZBI) Perceived caregiver burden (caregiver) 15 months
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03548779 - North Carolina Genomic Evaluation by Next-generation Exome Sequencing, 2 N/A
Completed NCT04435093 - Digitalization Playful Module of Motor Function Measure Assessment for Children With Neuromuscular Disorders, MFM-Play Pilot Study.
Not yet recruiting NCT04089696 - Validation of the "ExSpiron©" in Patients With ALS N/A
Not yet recruiting NCT05785546 - Elaboration of a Pronostic Score of Changes on Wheelchair's Seating System
Completed NCT01313325 - Hippotherapy to Improve the Balance of Children With Movement Disorders N/A
Recruiting NCT04098094 - Outcomes of RV Dysfunction in Acute Exacerbation of Chronic Respiratory Diseases
Active, not recruiting NCT05070624 - The Peer Support Study N/A
Completed NCT04729920 - Home Use of Mechanical Insufflation/Exsufflation Devices in Neuromuscular Diseases
Recruiting NCT04581577 - Perceptions of the Clinical and Psychosocial Impact of Covid-19 in Patients With Neuromuscular and Neurological Disorders
Completed NCT06428864 - Effect of the Use of a 3D Scanner Application on a Smartphone to Mold Garchois Orthotic Device in Neuromuscular Diseases Patients With Scoliosis
Enrolling by invitation NCT05539456 - Reliability and Validity of the Turkish Version of the PedsQL 3.0 Neuromuscular Module for 2-to 4- Year-old
Completed NCT05353738 - Efficacy of Vaccination Against COVID-19 in Patients Presenting a Neuromuscular Disease With Severe Amyotrophy
Recruiting NCT04541602 - Detection of Neuromuscular Complications in Critically Ill Patients
Completed NCT03394859 - Electronic Medical Records and Genomics (eMERGE) Phase III
Enrolling by invitation NCT05099107 - Changes of Motor Function Tests in Congenital Myopathy Subjects Treated With Oral Salbutamol as Compared to no Treatment N/A
Completed NCT05070910 - NDT Effectiveness Study N/A
Recruiting NCT04100993 - Multisystem and Autonomic Complications of NMD on Long-term NIV
Recruiting NCT04986059 - Effects of Pre-event Massage on Muscle Activity N/A
Completed NCT01022931 - Epidemiology and Clinical Presentation of H1N1 Infection in Children in Geneva N/A
Terminated NCT03353064 - Telemedicine for Improving Outcome in Inner City Patient Population With Hypercapneic Respiratory Failure N/A